Barclays’s Innovator US Equity Accelerated 9 Buffer ETF October XBOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.74K Sell
53
-10
-16% -$335 ﹤0.01% 4865
2025
Q4
$2.11K Sell
63
-5,761
-99% -$191K ﹤0.01% 5040
2025
Q3
$191K Buy
5,824
+1,130
+24% +$36.6K ﹤0.01% 4344
2025
Q2
$150K Sell
4,694
-79
-2% -$2.38K ﹤0.01% 4423
2025
Q1
$142K Buy
4,773
+1,244
+35% +$37.8K ﹤0.01% 4258
2024
Q4
$107K Buy
3,529
+3,528
+352,800% +$106K ﹤0.01% 4581
2024
Q3
$30 Buy
+1
New +$29 ﹤0.01% 5222

Other funds holding XBOC

Barclays's XBOC Position: Q1 2026 in Review

Barclays reduced its Innovator US Equity Accelerated 9 Buffer ETF October (XBOC) stake by 16% in Q1 2026, selling an estimated $335 and leaving 53 shares worth $1.74K. The position accounts for ﹤0.01% of the portfolio, ranked #4865.

Barclays first reported a position in XBOC in Q3 2024 and has held it in 7 quarters since. The position peaked at $191K in Q3 2025. 40 funds tracked by Wall St. Rank hold XBOC as of Q1 2026.

  • Barclays held 53 shares of Innovator US Equity Accelerated 9 Buffer ETF October worth $1.74K as of Q1 2026.
  • Barclays sold 10 Innovator US Equity Accelerated 9 Buffer ETF October shares in Q1 2026, an estimated $335.
  • Innovator US Equity Accelerated 9 Buffer ETF October made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4865 holding.
  • Barclays first reported a position in Innovator US Equity Accelerated 9 Buffer ETF October in Q3 2024 and has held it in 7 quarters since.
  • Barclays's Innovator US Equity Accelerated 9 Buffer ETF October position peaked at $191K in Q3 2025.
  • 40 funds tracked by Wall St. Rank held Innovator US Equity Accelerated 9 Buffer ETF October as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.